| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Terry Van Dyke | |
| Jessica J Hawes | |||
| Karlyne M Reilly | |||
| Jessica C Walrath | |||
| P2860 | cites work | Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer | Q21195235 |
| DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development | Q22010765 | ||
| The genomes of recombinant inbred lines | Q24544739 | ||
| CRE recombinase-inducible RNA interference mediated by lentiviral vectors | Q24562287 | ||
| Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector | Q24563904 | ||
| Cre-lox-regulated conditional RNA interference from transgenes | Q24564248 | ||
| Targeted oncogene activation by site-specific recombination in transgenic mice | Q24564632 | ||
| Tight control of gene expression in mammalian cells by tetracycline-responsive promoters | Q24564850 | ||
| Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach | Q24633776 | ||
| Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow | Q24645717 | ||
| Efficient tumour formation by single human melanoma cells | Q24648938 | ||
| The role of NKT cells in tumor immunity | Q24648939 | ||
| A transposon-based genetic screen in mice identifies genes altered in colorectal cancer | Q24655169 | ||
| Mouse xenograft models vs GEM models for human cancer therapeutics | Q24657555 | ||
| Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency | Q24800925 | ||
| The role of transgenic mouse models in carcinogen identification | Q24814156 | ||
| Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. | Q27824850 | ||
| A genetic model for colorectal tumorigenesis | Q27860582 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours | Q71767498 | ||
| Absence of secretory phospholipase A2 gene alterations in human colorectal cancer | Q71804941 | ||
| Transgenics at breaking-point | Q73466849 | ||
| atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity | Q73552961 | ||
| Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice | Q73715124 | ||
| Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression | Q74812416 | ||
| Enhanced tumor formation in mice heterozygous for Blm mutation | Q74813290 | ||
| Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice | Q78532668 | ||
| Animal models for disease: knockout, knock-in, and conditional mutant mice | Q79330719 | ||
| Tissue-specific transgenic and knockout mice | Q80161443 | ||
| Coevolution in the tumor microenvironment | Q81174508 | ||
| The Collaborative Cross, developing a resource for mammalian systems genetics: a status report of the Wellcome Trust cohort | Q81390325 | ||
| Bioluminescence technology for imaging cell proliferation | Q81428472 | ||
| Establishment of "The Gene Mine": a resource for rapid identification of complex trait genes | Q81808411 | ||
| Generalized lacZ expression with the ROSA26 Cre reporter strain | Q27860837 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Cancer predisposition caused by elevated mitotic recombination in Bloom mice | Q28139170 | ||
| Fate of the mammalian cardiac neural crest | Q28139176 | ||
| Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 | ||
| Oncogenic mechanisms of Evi-1 protein | Q28190419 | ||
| Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells | Q28201183 | ||
| Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells | Q28207586 | ||
| Mouse models for human DNA mismatch-repair gene defects | Q28214396 | ||
| Transforming pathways activated by the v-Abl tyrosine kinase | Q28217156 | ||
| Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice | Q28238747 | ||
| Cross-species oncogenomics in cancer gene identification | Q28249773 | ||
| Cancer stem cells: mirage or reality? | Q28257690 | ||
| Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation | Q28266922 | ||
| Second-generation shRNA libraries covering the mouse and human genomes | Q28275183 | ||
| Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines | Q28281211 | ||
| Mechanisms of gene silencing by double-stranded RNA | Q28282560 | ||
| The epigenomics of cancer | Q28289975 | ||
| Recombineering: a homologous recombination-based method of genetic engineering | Q28307909 | ||
| The lac operator-repressor system is functional in the mouse | Q28366874 | ||
| Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects | Q28511432 | ||
| The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system | Q28513603 | ||
| Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice | Q28590861 | ||
| Mouse models of tumor development in neurofibromatosis type 1 | Q28591083 | ||
| A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors | Q28592210 | ||
| Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis | Q28593625 | ||
| p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2 | Q28609749 | ||
| Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer | Q29547558 | ||
| Paradoxical roles of the immune system during cancer development | Q29614305 | ||
| Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy | Q29614312 | ||
| A molecular signature of metastasis in primary solid tumors | Q29614442 | ||
| NF-kappaB functions as a tumour promoter in inflammation-associated cancer | Q29614598 | ||
| IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer | Q29614599 | ||
| Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice | Q29616222 | ||
| Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis | Q29616631 | ||
| Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice | Q34549869 | ||
| A method for the generation of conditional gene repair mutations in mice | Q34582775 | ||
| Simulating the collaborative cross: power of quantitative trait loci detection and mapping resolution in large sets of recombinant inbred strains of mice | Q34588197 | ||
| PiggyBac transposon-mediated gene transfer in human cells | Q34590383 | ||
| Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse | Q34596182 | ||
| Maximizing mouse cancer models | Q34661270 | ||
| EUCOMM--the European conditional mouse mutagenesis program. | Q34707596 | ||
| Conditional transgenic mouse models: from the basics to genome-wide sets of knockouts and current studies of tissue regeneration. | Q34756517 | ||
| Maternal and zygotic Dnmt1 are necessary and sufficient for the maintenance of DNA methylation imprints during preimplantation development | Q34786920 | ||
| Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets | Q34796756 | ||
| The mifepristone-inducible gene regulatory system in mouse models of disease and gene therapy. | Q34870780 | ||
| RTCGD: retroviral tagged cancer gene database | Q34923778 | ||
| The Centre for Modeling Human Disease Gene Trap resource | Q34934856 | ||
| Human embryonic stem cells have a unique epigenetic signature | Q35012978 | ||
| Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes | Q35023096 | ||
| Astrocytes as stem cells: nomenclature, phenotype, and translation | Q35133562 | ||
| 10 years of mouse cancer modifier loci: human relevance | Q35156206 | ||
| Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis | Q35198652 | ||
| Cancer susceptibility in the mouse: genetics, biology and implications for human cancer | Q35209979 | ||
| Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis | Q35551846 | ||
| Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies | Q35652113 | ||
| Modeling sporadic loss of heterozygosity in mice by using mosaic analysis with double markers (MADM) | Q35663546 | ||
| New mouse models of cancer: single-cell knockouts | Q35721240 | ||
| Induced mitotic recombination of p53 in vivo | Q35721499 | ||
| Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice | Q35745271 | ||
| Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages | Q35761435 | ||
| Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. | Q35782743 | ||
| DNA repair factors and telomere-chromosome integrity in mammalian cells. | Q35783240 | ||
| Techniques: reporter mice - a new way to look at drug action. | Q35785779 | ||
| Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min mice | Q35836870 | ||
| Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels | Q35845232 | ||
| Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas. | Q35851152 | ||
| Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer | Q35901185 | ||
| Gene targeting and transgenic strategies for the analysis of hematopoietic development in the mouse. | Q35921914 | ||
| Tumorigenesis by slow-transforming retroviruses--an update | Q38012047 | ||
| Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors | Q38340343 | ||
| Induction of neural stem cell-like cells (NSCLCs) from mouse astrocytes by Bmi1. | Q38501282 | ||
| Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential | Q39720663 | ||
| A microarray-based DNA methylation study of glioblastoma multiforme | Q39834071 | ||
| Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. | Q40025706 | ||
| Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice | Q40386192 | ||
| Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras | Q40424687 | ||
| A public gene trap resource for mouse functional genomics | Q40550992 | ||
| The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis | Q40602468 | ||
| Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. | Q40731052 | ||
| Somatic activation of the K-ras oncogene causes early onset lung cancer in mice | Q40809826 | ||
| N-myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas | Q40816926 | ||
| Retroviral insertional mutagenesis as a strategy to identify cancer genes | Q40992682 | ||
| De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells | Q41161849 | ||
| The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta | Q41903591 | ||
| Is metastasis predetermined? | Q42342294 | ||
| Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development. | Q42724718 | ||
| Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse | Q42812392 | ||
| Site- and time-specific gene targeting in the mouse | Q43591560 | ||
| Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. | Q43693198 | ||
| Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib | Q43742602 | ||
| In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors. | Q44543288 | ||
| Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus | Q45828140 | ||
| Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus | Q45841107 | ||
| De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent | Q46068963 | ||
| Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1. | Q46097041 | ||
| Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacl shuttle vector | Q46416940 | ||
| Re-entry into the cell cycle is required for bFGF-induced oligodendroglial dedifferentiation and survival. | Q48860208 | ||
| A multifunctional reporter mouse line for Cre- and FLP-dependent lineage analysis. | Q50605367 | ||
| BAC rescue: a tool for functional analysis of the mouse genome. | Q50677638 | ||
| Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. | Q50794081 | ||
| Chromosomal translocation engineering to recapitulate primary events of human cancer. | Q51155518 | ||
| Bloom syndrome: a mendelian prototype of somatic mutational disease. | Q52222079 | ||
| Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. | Q52561781 | ||
| Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. | Q52567811 | ||
| Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. | Q53344889 | ||
| Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. | Q53346701 | ||
| Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. | Q53356315 | ||
| Telomere dysfunction provokes regional amplification and deletion in cancer genomes. | Q53387305 | ||
| Tumor spectrum in ARF-deficient mice. | Q53423902 | ||
| Bloom Syndrome | Q56482234 | ||
| The Collaborative Cross, a community resource for the genetic analysis of complex traits | Q56896214 | ||
| Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene | Q57274900 | ||
| Modeling Chromosomal Translocations Using Conditional Alleles to Recapitulate Initiating Events in Human Leukemias | Q58420381 | ||
| The invertor knock-in conditional chromosomal translocation mimic | Q58420386 | ||
| Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer | Q58420389 | ||
| An inflammatory link | Q59081065 | ||
| Re-entry into the cell cycle is required for bFGF-induced oligodendroglial dedifferentiation and survival | Q61799155 | ||
| Chromosomal Instability and Tumors Promoted by DNA Hypomethylation | Q63253103 | ||
| Metastasis results from preexisting variant cells within a malignant tumor | Q67602509 | ||
| Anti-angiogenesis: new concept for therapy of solid tumors | Q70493357 | ||
| Genetics of variation in HDL cholesterol in humans and mice | Q36002032 | ||
| New approaches for modelling cancer mechanisms in the mouse. | Q36004700 | ||
| Advances in imaging mouse tumour models in vivo | Q36004705 | ||
| Strategies for mapping and cloning quantitative trait genes in rodents | Q36085684 | ||
| Metastasis predictive signature profiles pre-exist in normal tissues | Q36103292 | ||
| Tissue-specific and reversible RNA interference in transgenic mice | Q36129232 | ||
| Probing p53 biological functions through the use of genetically engineered mouse models | Q36204567 | ||
| Retroviral insertional mutagenesis: past, present and future | Q36318150 | ||
| Contributions of human tumor xenografts to anticancer drug development | Q36439483 | ||
| The inflammatory tumor microenvironment and its impact on cancer development | Q36455107 | ||
| Mouse models of human non-small-cell lung cancer: raising the bar. | Q36547732 | ||
| Dissecting cancer pathways and vulnerabilities with RNAi | Q36547770 | ||
| Application and potential limitations of animal models utilized in the development of trastuzumab (Herceptin): a case study | Q36550493 | ||
| The mighty mouse: genetically engineered mouse models in cancer drug development | Q36568461 | ||
| Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects | Q36602578 | ||
| Mouse modeling in oncologic preclinical and translational research | Q36603691 | ||
| Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice | Q36622112 | ||
| The cancer stem cell hypothesis: a work in progress | Q36639832 | ||
| The mouse as a model for human biology: a resource guide for complex trait analysis | Q36685876 | ||
| Modeling non-random deletions in cancer | Q36686264 | ||
| Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks | Q36688585 | ||
| How is pluripotency determined and maintained? | Q36704169 | ||
| Xenograft models for the preclinical evaluation of new therapies in acute leukemia | Q36799846 | ||
| A system for Cre-regulated RNA interference in vivo | Q36868413 | ||
| Tumor angiogenesis: cause or consequence of cancer? | Q36899936 | ||
| Large-scale gene trapping in C57BL/6N mouse embryonic stem cells. | Q36915086 | ||
| Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors. | Q36941057 | ||
| A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice | Q36980093 | ||
| NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis | Q36982958 | ||
| Tumor stroma and regulation of cancer development | Q37014752 | ||
| Quiet as a mouse: dissecting the molecular and genetic basis of hearing | Q37087936 | ||
| No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas | Q37098932 | ||
| Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies | Q37121291 | ||
| The use of xenograft models for the selection of cancer treatments with the EGFR as an example. | Q37128868 | ||
| Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century | Q34423288 | ||
| An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model | Q34448414 | ||
| Harnessing preclinical mouse models to inform human clinical cancer trials. | Q34498952 | ||
| Genetically engineered models have advantages over xenografts for preclinical studies | Q34508688 | ||
| Neurofibromas in NF1: Schwann cell origin and role of tumor environment | Q34509108 | ||
| Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma | Q34509145 | ||
| Cancer modeling in the modern era: progress and challenges | Q34520417 | ||
| The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy | Q37143395 | ||
| Development of a novel mouse glioma model using lentiviral vectors | Q37164106 | ||
| Inflammation: gearing the journey to cancer | Q37166066 | ||
| Is tumor growth sustained by rare cancer stem cells or dominant clones? | Q37179962 | ||
| Molecular-genetic imaging based on reporter gene expression | Q37181554 | ||
| Imatinib mesylate for the treatment of chronic myeloid leukemia | Q37183434 | ||
| Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming. | Q37189326 | ||
| Glioma formation, cancer stem cells, and akt signaling | Q37205122 | ||
| The future of mouse QTL mapping to diagnose disease in mice in the age of whole-genome association studies | Q37256790 | ||
| VEGF inhibition: insights from preclinical and clinical studies | Q37259271 | ||
| A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. | Q37266967 | ||
| Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins | Q37267377 | ||
| Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner | Q37267802 | ||
| Alterations of DNA methylation and clinicopathological diversity of human cancers | Q37272742 | ||
| Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers | Q37272977 | ||
| The analysis of metastasis in transgenic mouse models | Q37323450 | ||
| Applications of lentiviral vectors for shRNA delivery and transgenesis | Q37347170 | ||
| Genetically engineered mouse models of brain cancer and the promise of preclinical testing | Q37348716 | ||
| The Collaborative Cross at Oak Ridge National Laboratory: developing a powerful resource for systems genetics | Q37349416 | ||
| Pharmacogenetics in breast cancer therapy | Q37352437 | ||
| In vivo/ex vivo and in situ assays used in cancer research: a brief review | Q37355404 | ||
| Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations | Q37363083 | ||
| Clonality of mouse and human cardiomyogenesis in vivo | Q37385968 | ||
| Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality | Q37407179 | ||
| Chromosome engineering in ES cells | Q37407918 | ||
| An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. | Q37486791 | ||
| High-throughput insertional mutagenesis screens in mice to identify oncogenic networks | Q37492234 | ||
| Target-based therapies in breast cancer: current status and future perspectives. | Q37518897 | ||
| Humanized mice for modeling human infectious disease: challenges, progress, and outlook. | Q37555592 | ||
| Ecdysone-inducible gene expression in mammalian cells and transgenic mice. | Q37651825 | ||
| Antiangiogenic therapy of transgenic mice impairs de novo tumor growth | Q37707900 | ||
| Viral etiology of cancer and leukemia: a look into the past, present and future--G.H.A. Clowes Memorial Lecture | Q37719008 | ||
| Systemic spread is an early step in breast cancer | Q29617041 | ||
| Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells | Q29617246 | ||
| Induction of Tumors in Mice by Genomic Hypomethylation | Q29618551 | ||
| Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells | Q29618944 | ||
| Atm-deficient mice: a paradigm of ataxia telangiectasia | Q29619532 | ||
| Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging | Q29619816 | ||
| Tumorigenesis and the angiogenic switch | Q29619849 | ||
| Essential role of mouse telomerase in highly proliferative organs | Q29620451 | ||
| Talking about a Revolution | Q30050478 | ||
| Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control | Q30485941 | ||
| Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase | Q30490786 | ||
| Interaction between bevacizumab and murine VEGF-A: a reassessment | Q30840642 | ||
| Molecular characterization of the tumor microenvironment in breast cancer | Q31095898 | ||
| Mutagenic insertion and chromosome engineering resource (MICER). | Q33204468 | ||
| Genomewide production of multipurpose alleles for the functional analysis of the mouse genome | Q33214664 | ||
| Mammalian RNAi: a practical guide | Q33222125 | ||
| Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. | Q33222808 | ||
| Insights into cancer from transgenic mouse models | Q33643327 | ||
| Transformation by v-Myb | Q33667366 | ||
| Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells | Q33715154 | ||
| Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse. | Q33758222 | ||
| Tumor cells utilize multiple pathways to down-modulate apoptosis. Lessons from a mouse model of islet cell carcinogenesis | Q33834246 | ||
| Analysing complex genetic traits with chromosome substitution strains | Q33853268 | ||
| p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis | Q33862956 | ||
| Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice | Q33914498 | ||
| A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells | Q33938488 | ||
| Identifying novel genes for atherosclerosis through mouse-human comparative genetics | Q34021005 | ||
| Recent advances in the protocols of transgenic mouse mutation assays. | Q34102919 | ||
| Inducing cellular dedifferentiation: a potential method for enhancing endogenous regeneration in mammals | Q34151642 | ||
| Retinoblastoma tumor suppressor and genome stability | Q34153888 | ||
| Angiogenesis in transgenic models of multistep carcinogenesis | Q34178915 | ||
| Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo | Q34312741 | ||
| The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia | Q34313013 | ||
| Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse | Q34344768 | ||
| Modeling metastasis in vivo | Q34347247 | ||
| Transcription and processing of human microRNA precursors | Q34378218 | ||
| P304 | page(s) | 113-164 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Advances in Cancer Research | Q3113522 |
| P1476 | title | Genetically engineered mouse models in cancer research | |
| P478 | volume | 106 |
| Q90043616 | Animal Models to Study Cancer and Its Microenvironment |
| Q91142488 | CRISPR-Cas: a tool for cancer research and therapeutics |
| Q90290673 | Cancer Chemoprevention: Preclinical In Vivo Alternate Dosing Strategies to Reduce Drug Toxicities |
| Q46900302 | Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance. |
| Q55368630 | Canine mammary tumors as a model for human disease. |
| Q36549790 | Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations |
| Q104795307 | Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts |
| Q55054189 | Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders? |
| Q34679234 | Cyclin E transgenic mice: discovery tools for lung cancer biology, therapy, and prevention |
| Q99237685 | Developing preclinical models of neuroblastoma: driving therapeutic testing |
| Q21131727 | Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy |
| Q46237480 | Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1). |
| Q42371459 | Exome sequencing analysis of murine medulloblastoma models identifies WDR11 as a potential tumor suppressor in Group 3 tumors |
| Q36372990 | Finding mouse models of human lymphomas and leukemia's using the Jackson laboratory mouse tumor biology database. |
| Q28079323 | Genetically engineered mouse models in oncology research and cancer medicine |
| Q34332175 | Genetically engineered mouse models of PI3K signaling in breast cancer |
| Q47111892 | Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer |
| Q90712068 | Genomic evolution of cancer models: perils and opportunities |
| Q38957511 | Heralding a new paradigm in 3D tumor modeling |
| Q47575408 | Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model |
| Q34280457 | Identifying mouse models for skin cancer using the Mouse Tumor Biology Database |
| Q38221430 | Imaging preclinical tumour models: improving translational power |
| Q91992239 | Inhibition of LTA4H by bestatin in human and mouse colorectal cancer |
| Q35043525 | Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review. |
| Q90470236 | Mitochondrial polymorphisms contribute to aging phenotypes in MNX mouse models |
| Q38719044 | Mouse Models of Breast Cancer: Platforms for Discovering Precision Imaging Diagnostics and Future Cancer Medicine |
| Q35254961 | Mouse Tumor Biology (MTB): a database of mouse models for human cancer |
| Q90221026 | Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma |
| Q42559273 | Mouse models for cancer research |
| Q58776633 | Mouse models in the era of large human tumour sequencing studies |
| Q37896219 | Mouse models of medulloblastoma |
| Q51149956 | Multiplexed MRM-based assays for the quantitation of proteins in mouse plasma and heart tissue. |
| Q27023342 | One mouse, one patient paradigm: New avatars of personalized cancer therapy |
| Q38438690 | PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias. |
| Q37327639 | PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts |
| Q47927484 | Pathways from senescence to melanoma: focus on MITF sumoylation. |
| Q39642260 | Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias. |
| Q49475238 | Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer. |
| Q38795324 | Preclinical Mouse Models for Analysis of the Therapeutic Potential of Engineered Oncolytic Herpes Viruses |
| Q27322080 | Preclinical mouse cancer models: a maze of opportunities and challenges |
| Q38556243 | Rapid validation of cancer genes in chimeras derived from established genetically engineered mouse models |
| Q90663246 | Simple and large-scale chromosomal engineering of mouse zygotes via in vitro and in vivo electroporation |
| Q40388813 | Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis |
| Q34628001 | Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease. |
| Q33808204 | The Mouse Tumor Biology Database (MTB): a central electronic resource for locating and integrating mouse tumor pathology data. |
| Q33740762 | The N-Glycosylation of Mouse Immunoglobulin G (IgG)-Fragment Crystallizable Differs Between IgG Subclasses and Strains |
| Q37742632 | The biology of uveal melanoma |
| Q58804592 | The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research |
| Q92085863 | The design, analysis and application of mouse clinical trials in oncology drug development |
| Q57049688 | The importance of cancer cells for animal evolutionary ecology |
| Q38724273 | Three-dimensional cell culture models for anticancer drug screening: Worth the effort? |
| Q35130666 | Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells |
| Q56898750 | White paper on microbial anti-cancer therapy and prevention |
| Q28077396 | Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches |
Search more.